Tech-Based Caregiver Support for Alzheimer's Disease
(TACAD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial evaluates a tech-based support program designed to assist Asian American midlife women caring for family members with Alzheimer's disease. Researchers aim to determine if this program, called TACAD (Technology-based information and coaching/support program tailored for Asian American midlife women who are family caregivers of patients living with Alzheimer's disease), can improve health outcomes for both caregivers and their loved ones. Participants will either use the TACAD program along with the Alzheimer's Association Website or just the website alone. Ideal candidates are Asian American women, aged 40 to 65, who provide at least four hours of daily care to a family member with early to middle-stage Alzheimer's, live in the U.S., and have internet access. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance caregiver support and improve quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the TACAD program is safe for caregivers?
Research has shown that the TACAD program is a tech-based support system designed to assist Asian American women caring for family members with Alzheimer's. Although specific data on TACAD's safety is not available, it is likely safe as it is a technology program, not a medication. Tech-based programs typically offer information and support without the side effects associated with medications. The program uses online resources, which generally do not pose safety risks.12345
Why are researchers excited about this trial?
Researchers are excited about TACAD for Alzheimer's disease because it offers tech-based support specifically for caregivers, which is not a focus of existing treatments. Unlike the standard of care that primarily involves medications like donepezil or rivastigmine aimed at slowing cognitive decline in patients, TACAD leverages technology to enhance caregiver support. By integrating the use of the Alzheimer's Association Website with TACAD, this approach could improve caregiver well-being and, in turn, positively impact patient care. This innovation could lead to a more holistic management of Alzheimer's by addressing the needs of both patients and their caregivers.
What evidence suggests that the TACAD program is effective for supporting caregivers of Alzheimer's patients?
Research shows that technology-based support programs like TACAD, available to participants in this trial, can help caregivers improve their health. These programs offer information and guidance specifically for Asian American women in midlife caring for loved ones with Alzheimer's disease. Early results suggest that personalized support can lower stress and enhance caregivers' well-being. Although specific data on TACAD is still being gathered, similar programs have demonstrated positive effects on mental health and have alleviated challenges faced by caregivers. This suggests that TACAD might effectively provide essential support and relief for these caregivers.12467
Who Is on the Research Team?
Eun-Ok Im, PhD, MPH
Principal Investigator
University of Texas at Austin
Are You a Good Fit for This Trial?
This trial is for Asian American women, aged 40-65, who are Chinese or Korean and care for family members with early to middle-stage Alzheimer's. They must read/write English, Mandarin, or Korean, live in the U.S., have internet access, and provide at least 4 hours of daily unpaid care without plans for institutionalizing the patient within six months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a technology-based program for 3 months, with weekly group and individual coaching/support for the intervention group.
Follow-up
Participants are monitored for changes in caregiver and care recipient outcomes through Internet surveys.
What Are the Treatments Tested in This Trial?
Interventions
- Alzheimer's Association website
- TACAD
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor
Emory University
Lead Sponsor